Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study

被引:74
|
作者
Jakimovski, D. [1 ]
Gandhi, S. [1 ]
Paunkoski, I. [1 ]
Bergsland, N. [1 ]
Hagemeier, J. [1 ]
Ramasamy, D. P. [1 ]
Hojnacki, D. [2 ]
Kolb, C. [2 ]
Benedict, R. H. B. [2 ]
Weinstock-Guttman, B. [2 ]
Zivadinov, R. [1 ,3 ]
机构
[1] SUNY Buffalo, Dept Neurol, Jacobs Sch Med & Biomed Sci, Buffalo Neuroimaging Anal Ctr, Buffalo, NY USA
[2] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Jacobs Comprehens MS Treatment & Res Ctr, Buffalo, NY USA
[3] SUNY Buffalo, Clin Translat Sci Inst, Ctr Biomed Imaging, Buffalo, NY USA
基金
美国国家卫生研究院;
关键词
brain atrophy; heart disease; hypertension; lateral ventricular volume; MRI; multiple sclerosis; LIPID PROFILE; SMOKING; COMORBIDITY; PROGRESSION; DISABILITY; INCREASES; VOLUMES; DELAYS; RISK;
D O I
10.1111/ene.13769
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Cardiovascular diseases (CVDs) are more frequent in multiple sclerosis (MS) patients when compared to controls. In particular, CVDs are linked with higher accumulation of lesions and advanced brain atrophy. Objective To investigate whether CVDs contribute to accelerated lesion accumulation and brain atrophy over 5 years in patients with MS. Methods 194 MS patients and 43 controls without neurologic disease were followed for 5 years. Full physical, neurological evaluation, and structured questionnaire investigating CVD and risk factors (hypertension, hyperlipidemia, heart disease, smoking, diabetes, obesity/overweight) were collected using interview-based questionnaire and further cross-reference with electronic medical records. Lesion and brain atrophy outcomes were assessed with 3T MRI. ANCOVA adjusted for age, gender, and disease duration were used accordingly. False discovery rate correction was performed using Benjamini-Hochberg correction. Results Patients with diagnosis of heart disease showed higher white matter and whole brain volume loss compared to those without (-4.2% vs. -0.7%, P = 0.01 and -3.4% vs. -1.6%, P = 0.01, respectively). The percentage lateral ventricle volume change in MS patients with hypertension was higher compared to non-hypertensive patients (24.5% vs. 14.1%, P = 0.05). Hyperlipidemia, smoking, and obesity/overweight were not associated with progression of MRI-derived outcomes. CVDs did not contribute to larger lesion volume accrual over the 5-year period. The presence of CVDs was not associated with MRI-derived changes in the controls. Conclusions Hypertension and heart disease contribute to advanced brain atrophy in MS patients. CVDs did not contribute to additional lesion accrual. CVD comorbidities in MS patients may contribute to neurodegenerative tissue injury that can be detected with brain MRI.
引用
收藏
页码:87 / +
页数:8
相关论文
共 50 条
  • [1] Hypertension and heart disease are independently associated with development of brain atrophy in multiple sclerosis patients. A 5-year longitudinal study
    Jakimovski, Dejan
    Gandhi, Sirin
    Paunkoski, Ivo
    Bergsland, Niels
    Hagemeier, Jesper
    Ramasamy, Deepa
    Hojnacki, David
    Kolb, Channa
    Weinstock-Guttman, Bianca
    Zivadinov, Robert
    NEUROLOGY, 2018, 90
  • [2] Optical Coherence Tomography Is Associated with Development of Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Longitudinal 5-Year Follow-Up Study
    Gandhi, Sirin
    Hagemeier, Jesper
    Chandra, Avinash
    Sanai, Shaik Ahmed
    Jakimovski, Dejan
    Ahmed, Rahil
    Ramaswamy, Deepa
    Bergsland, Niels
    Guttman, Bianca
    Zivadinov, Robert
    NEUROLOGY, 2016, 86
  • [3] Blood serum proteome correlates of multiple sclerosis disease progression as evaluated by clinical and brain atrophy outcomes: a 5-year longitudinal study
    Gehman, V.
    Jakimovski, D.
    Qureshi, F.
    Ramanathan, M.
    Zhang, F.
    Bergsland, N.
    Da Costa, F. Rubio
    Dwyer, M.
    Weinstock-Guttman, B.
    Zivadinov, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 582 - 583
  • [4] Brain Atrophy in Natalizumab-treated Patients with Multiple Sclerosis: A 5-year Retrospective Study
    Eisele, Philipp
    Szabo, Kristina
    Ebert, Anne
    Platten, Michael
    Gass, Achim
    JOURNAL OF NEUROIMAGING, 2019, 29 (02) : 190 - 192
  • [5] A 10-year longitudinal study of brain atrophy in multiple sclerosis
    Fisher, E.
    Lee, J. -C.
    Rudick, R. A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S153 - S153
  • [6] Spinal cord lesions and brain grey matter atrophy predict 5-year multiple sclerosis disease worsening
    Rocca, M.
    Valsasina, P.
    Meani, A.
    Gobbi, C.
    Zecca, C.
    Barkhof, F.
    Schoonheim, M.
    Strijbis, E.
    Vrenken, H.
    Gallo, A.
    Bisecco, A.
    Ciccarelli, O.
    Yiannakas, M.
    Rovira, A.
    Sastre-Garriga, J.
    Palace, J.
    Matthews, L.
    Gass, A.
    Eisele, P.
    Lukas, C.
    Bellenberg, B.
    Margoni, M.
    Preziosa, P.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 294 - 294
  • [7] A longitudinal study of brain atrophy in relapsing multiple sclerosis
    Simon, JH
    Jacobs, LD
    Campion, MK
    Rudick, RA
    Cookfair, DL
    Herndon, RM
    Richert, JR
    Salazar, AM
    Fischer, JS
    Goodkin, DE
    Simonian, N
    Lajaunie, M
    Miller, DE
    Wende, K
    Martens-Davidson, A
    Kinkel, RP
    Munschauer, FE
    Brownscheidle, CM
    NEUROLOGY, 1999, 53 (01) : 139 - 148
  • [8] Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
    Hanninen, Katariina
    Viitala, Matias
    Paavilainen, Teemu
    Karhu, Jari O.
    Rinne, Juha
    Koikkalainen, Juha
    Lotjonen, Jyrki
    Soilu-Hanninen, Merja
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [9] Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis A 5-year longitudinal study
    Horakova, Dana
    Dwyer, Michael G.
    Havrdova, Eva
    Cox, Jennifer L.
    Dolezal, Ondrej
    Bergsland, Niels
    Rimes, Brett
    Seidl, Zdenek
    Vaneckova, Manuela
    Zivadinov, Robert
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 282 (1-2) : 112 - 119
  • [10] Longitudinal Study of Cognitive Impairment in Multiple Sclerosis: A 5-year Follow-up
    Kuscu, Demet Yandim
    Kandemir, Melek
    Unal, Aysun
    Topcular, Baris
    Kirbas, Dursun
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (01): : 29 - 32